These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 20544328)

  • 1. Delivery of siRNA therapeutics: barriers and carriers.
    Wang J; Lu Z; Wientjes MG; Au JL
    AAPS J; 2010 Dec; 12(4):492-503. PubMed ID: 20544328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular assemblies in functional siRNA delivery: where do we stand?
    Aliabadi HM; Landry B; Sun C; Tang T; Uludağ H
    Biomaterials; 2012 Mar; 33(8):2546-69. PubMed ID: 22209641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA based drug design, quality, delivery and clinical translation.
    Subhan MA; Torchilin VP
    Nanomedicine; 2020 Oct; 29():102239. PubMed ID: 32544449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA therapeutics: a clinical reality.
    Saw PE; Song EW
    Sci China Life Sci; 2020 Apr; 63(4):485-500. PubMed ID: 31054052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of siRNA to the target cell cytoplasm: photochemical internalization facilitates endosomal escape and improves silencing efficiency, in vitro and in vivo.
    Oliveira S; Høgset A; Storm G; Schiffelers RM
    Curr Pharm Des; 2008; 14(34):3686-97. PubMed ID: 19075744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycation-based nanoparticle delivery for improved RNA interference therapeutics.
    Howard KA; Kjems J
    Expert Opin Biol Ther; 2007 Dec; 7(12):1811-22. PubMed ID: 18034647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAMAM Dendrimers as a Delivery System for Small Interfering RNA.
    Kheiriabad S; Ghaffari M; Dolatabadi JEN; Hamblin MR
    Methods Mol Biol; 2020; 2115():91-106. PubMed ID: 32006396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-viral nanosystems for systemic siRNA delivery.
    David S; Pitard B; Benoît JP; Passirani C
    Pharmacol Res; 2010 Aug; 62(2):100-14. PubMed ID: 20006707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of short interfering RNAs--strategies for in vivo delivery.
    Wullner U; Neef I; Tur MK; Barth S
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):1-8. PubMed ID: 19149683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
    Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
    Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of non-viral vectors for siRNA delivery].
    Yang FF; Huang W; Li YF; Gao ZG
    Yao Xue Xue Bao; 2011 Dec; 46(12):1436-43. PubMed ID: 22375415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
    Bolhassani A; Milani A
    Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference therapeutics for cancer: challenges and opportunities (review).
    Bora RS; Gupta D; Mukkur TK; Saini KS
    Mol Med Rep; 2012 Jul; 6(1):9-15. PubMed ID: 22576734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.
    Draz MS; Fang BA; Zhang P; Hu Z; Gu S; Weng KC; Gray JW; Chen FF
    Theranostics; 2014; 4(9):872-92. PubMed ID: 25057313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering siRNA therapeutics: challenges and strategies.
    Ali Zaidi SS; Fatima F; Ali Zaidi SA; Zhou D; Deng W; Liu S
    J Nanobiotechnology; 2023 Oct; 21(1):381. PubMed ID: 37848888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector.
    Tekade RK; Maheshwari RG; Sharma PA; Tekade M; Chauhan AS
    Curr Pharm Des; 2015; 21(31):4614-36. PubMed ID: 26486147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of polymers for short interfering RNA delivery in vascular smooth muscle cells.
    Bools LM; Fisher RK; Grandas OH; Kirkpatrick SS; Arnold JD; Goldman MH; Freeman MB; Mountain DJ
    J Surg Res; 2015 Nov; 199(1):266-73. PubMed ID: 26272685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
    Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
    Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.